Doolan D L, Saul A J, Good M F
Tropical Health Program, Queensland Institute of Medical Research, Bancroft Centre, Brisbane, Australia.
Infect Immun. 1992 Feb;60(2):675-82. doi: 10.1128/iai.60.2.675-682.1992.
The design of a subunit vaccine against the malaria parasite relies on the epitopes recognized by T cells being identified and polymorphisms therein being defined. Here we present the analysis of a 354-bp fragment of the circumsporozoite (CS) protein encompassing defined proliferative and cytotoxic T-cell recognition regions. We reveal that the polymorphism of CS protein T-cell sites appears to be very limited among Plasmodium falciparum isolates prevalent in certain geographical regions, in particular Papua New Guinea. Furthermore, the more extensive polymorphism noted in other areas appears to be restricted. Although the extent of variation observed for the T-cell recognition domains suggests that any vaccine designed to stimulate this form of immunity will need to be polyvalent, this variation appears to be finite and the combination of peptides necessary for inclusion in a polyvalent vaccine may be small. If ways to increase immune responsiveness can be found, then a vaccine designed to stimulate CS protein-specific T-cell activity may prevent malaria.
抗疟原虫亚单位疫苗的设计依赖于识别T细胞所识别的表位并确定其中的多态性。在此,我们展示了对包含特定增殖性和细胞毒性T细胞识别区域的环子孢子(CS)蛋白354bp片段的分析。我们发现,在某些地理区域(特别是巴布亚新几内亚)流行的恶性疟原虫分离株中,CS蛋白T细胞位点的多态性似乎非常有限。此外,在其他地区观察到的更广泛的多态性似乎受到限制。尽管T细胞识别域观察到的变异程度表明,任何旨在刺激这种免疫形式的疫苗都需要是多价的,但这种变异似乎是有限的,多价疫苗中所需包含的肽的组合可能很少。如果能找到提高免疫反应性的方法,那么设计用于刺激CS蛋白特异性T细胞活性的疫苗可能预防疟疾。